GlassScriptPhysician profile
Elvis Tako
NPI 1689248916
$1,267.54
in general payments reported to CMS, 2019-2025
15 companies · $794 in 2025
The $794 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $180 · 2023: $241 · 2024: $52.10 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.17 |
| Travel and Lodging | $435.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $435.40 | 2025 | |
| Integra Lifesciences Corporation | $153.76 | 2022 | |
| Horizon Therapeutics Plc | $123.50 | 2023 | Krystexxa |
| Nevro Corp. | $117.61 | 2023 | Senza |
| Stryker Corporation | $78.31 | 2022-2024 | Salvation |
| Organogenesis INC. | $60.97 | 2025 | Affinity, Apligraf, Via Matrix |
| Biocomposites INC | $52.37 | 2025 | Stimulan |
| Globus Medical, INC. | $52.24 | 2025 | Senza |
| Smith+Nephew, INC. | $50.76 | 2025 | Stravix, Grafix Pl |
| Averitas Pharma INC. | $48.59 | 2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $28.82 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $21.35 | 2025 | Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $20.20 | 2025 | |
| Aroa Biosurgery Incorporated | $16.94 | 2025 | |
| Lifenet Health | $6.72 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elvis Tako listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.